soul trial oral semaglutide cardiovascular outcomes 2025 results align more closely with attained dose than achieved weight loss Frontiers | Effects of subcutaneous

High alcohol intake

A new review from the Schmidt lab at Penn pulls the preclinical and emerging clinical evidence together

Rowlands, D

Anti-inflammatory Effects: Beyond appetite regulation, emerging research suggests that GLP-1 therapies may also contribute to lowering CRP (C-reactive protein), a key inflammatory marker

Compounded vials let you draw any amount, which gives providers the ability to prescribe intermediate doses like 0.375 mg or 1.25 mg for patients who need a gentler microdosing approach

When people desperately want something they cannot easily get, they become more susceptible to products that promise a convenient alternative